Maria Langkilde

Featured in:

Articles

Dapagliflozin and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction: The DELIVER trial

Dec 12, 2023 | eprints.gla.ac.uk | Zi Michael |Carolyn S.P |De Boer |Maria Langkilde

Ostrominski, J. W. et al. (2023) Dapagliflozin and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction: The DELIVER trial. Circulation, 148(24), pp. 1945-1957. (doi: 10.1161/circulationaha.123.065254) (PMID:37830208) Full text not currently available from Enlighten.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.